EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).

Supporters of EVISA includes:

Yaoxue-xuebao : yuekan = Acta pharmaceutica Sinica

(Chinese journal of pharmacology)


Chinese Biomedical Data Base, Chinese Scientific Literature Data Base, Chinese Pharmaceutical Abstracts (CPA), Data Base of Names of the Titles of Chinese Scientific Journals, Data Base of Chinese Academic Journals (CD), Abstract of Chinese Medicine (ACME) and Chemical Abstracts (CA), Abstract Journal(AJ), Biological Abstracts (BA), Index Medicus (IM/Medline), International Pharmaceutical Abstracts (IPA).

Source type
First volume
Last volume
Publish city

Acta Pharmaceutica Sinica (APS) started its publication in July 1953 following its predecessor “Chinese Journal of Pharmaceutical Sciences” which was started in 1936. The APS is devoted to original research articles on pharmaceutical sciences including pharmacology, toxicology, pharmacy, pharmacognosy, antibiotics, chemistry of natural products, pharmaceutical chemistry and pharmaceutical analysis. Research articles, communications, reviews and commentaries introducing new theories and new technologies are also published. Readers of the APS are supposed to be mainly those involved in scientific research and those pertaining to higher education. Papers in The APS are mainly written in Chinese with an abstract in English. However, all tables, figures and references are in English. Papers in English are also published but with an abstract in Chinese.

In the list of 1000 journals most frequently cited in Chemical Abstracts, the APS ranked in the front of the Chinese medical journals. According to statistics of the database of the Chinese science literature the number of citations of the APS ranked seven among 500 Chinese journals and the first among biomedical journals during the last five years. The total citation rate and impact factor of the APS in 2004 were 2778, and 0.962, respectively. It won the 1st “National Prize for Chinese Journals” in 1999 and was selected as the “Journal of High Popularity and High Academic Level” in the “Phalanx of Chinese Journals” in 2001. It also won the 2nd “ National Prize for Chinese Journals (100 Key Science and Technological Journals)” and the 3rd “ Prize for Chinese Excellent Science and Technological Journals” in 2002.

Related links:

Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )